Innoviva (INVA) Receivables (2012 - 2026)

Innoviva has reported Receivables for 9 years, with the latest figure at $92.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 18.85% year-over-year to $92.6 million; the trailing twelve-month figure through Mar 2026 stood at $92.6 million (up 18.85% YoY), and the FY2025 full-year result was $93.3 million, up 8.05% from the prior year.
• Receivables for Q1 2026 stood at $92.6 million, down from $93.3 million in the prior quarter.
• The five-year high for Receivables was $94.0 million in Q2 2024, with the low at $64.1 million in Q4 2022.
• Historically, Receivables has averaged $82.5 million across 5 years, with a median of $84.1 million in 2023.
• Annual changes were most pronounced in 2022 — Receivables surged 50.79% — and 2023, when it dropped 6.33%.
• Innoviva's Receivables stood at $64.1 million in 2022, then soared by 31.22% to $84.1 million in 2023, then rose by 2.72% to $86.4 million in 2024, then increased by 8.05% to $93.3 million in 2025, then retreated by 0.74% to $92.6 million in 2026.
• The last three Receivables figures came in at $92.6 million (Q1 2026), $93.3 million (Q4 2025), and $93.5 million (Q3 2025), per Business Quant data.